Zoetis Financial Ratios
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Zoetis ratio analysis
Zoetis earned a net margin of 28.2% in FY 2025, up from 26.9% a year earlier. Gross margin was 71.8% compared with a median of 69.2% over the prior 9 years. Return on equity reached 78.3%, meaning Zoetis generated 0.78 dollars of profit for every dollar of shareholders' equity, an unusually high figure that often reflects a small equity base after share buybacks.
Debt-to-equity stood at 2.65 versus 1.38 the year before, and the current ratio was 3.12. At the end of FY 2025, ZTS traded at 20.9 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 20.9 to 57.1, with a median of 35.8. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Zoetis financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 20.92 | 29.86 | 38.93 | 32.64 | 57.15 | 48.39 | 43.14 | 28.93 | 41.17 | 32.44 |
| Price / sales | 5.90 | 8.01 | 10.65 | 8.50 | 14.89 | 11.79 | 10.25 | 7.03 | 6.65 | 5.43 |
| Price / book | 16.35 | 15.55 | 18.22 | 15.60 | 25.48 | 20.88 | 23.69 | 18.74 | 19.94 | 17.85 |
| Gross margin | 71.8% | 70.6% | 70.0% | 69.6% | 70.4% | 69.2% | 68.2% | 67.2% | 66.6% | 65.9% |
| Net margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | 24.5% | 24.0% | 24.5% | 16.3% | 16.8% |
| Free cash flow margin | 24.1% | 24.8% | 19.0% | 16.4% | 22.3% | 25.1% | 21.3% | 24.9% | 21.1% | 10.2% |
| Return on equity (ROE) | 78.3% | 52.1% | 46.9% | 48.0% | 44.8% | 43.5% | 55.4% | 65.4% | 48.8% | 55.2% |
| Return on assets (ROA) | 17.3% | 17.5% | 16.4% | 14.2% | 14.7% | 12.0% | 13.0% | 13.3% | 10.1% | 10.7% |
| Debt / equity | 2.65 | 1.38 | 1.31 | 1.79 | 1.45 | 1.91 | 2.38 | 2.95 | 2.80 | 3.00 |
| Current ratio | 3.12 | 1.75 | 3.36 | 2.37 | 3.86 | 3.05 | 2.63 | 3.60 | 3.85 | 3.03 |
| Revenue growth | 2.3% | 8.3% | 5.7% | 3.9% | 16.5% | 6.6% | 7.5% | 9.8% | 8.6% | 2.6% |
| EPS growth | 10.1% | 7.9% | 12.9% | 5.2% | 24.9% | 10.0% | 6.1% | 67.4% | 6.1% | 142.6% |